Brain & NeuroscienceResearch
Exploring the Relationship Between Maternal Immune Activation During Pregnancy and Autism
Emerging research examines how immune responses during pregnancy may influence fetal brain development, contributing to our understanding of autism's diverse origins.
Understanding Immune Activation During Pregnancy
Research suggests that when a pregnant person's immune system responds to infections or inflammation (a process called maternal immune activation or MIA), it may influence fetal brain development in various ways. A primate study published in Molecular Psychiatry found that MIA leads to changes in gene expression in the amygdala, a brain region involved in social behavior, detectable in offspring long after birth.
The Importance of Timing
The stage of pregnancy when immune activation occurs appears significant. Research indicates that the third trimester (approximately weeks 28-40) may be particularly influential. A study in Nature analyzing birth cohorts found that certain immune molecules in maternal and umbilical cord blood could correlate with later autism diagnoses. Exposure to fine particulate air pollution (PM2.5) during this period was associated with a modest increase in autism likelihood, from about 1.7% to 2.1% in large studies.
Biological Pathways
Scientists are exploring how immune activation might relate to neurodevelopmental differences. The Simons Foundation Autism Research Initiative reported that certain immune markers (like IL-6 and IL-17a) during pregnancy and at birth showed correlations with later autism diagnoses. These findings build on earlier work showing immune responses can influence fetal brain development through inflammatory pathways.
COVID-19 Considerations
The pandemic has prompted new research into viral infections during pregnancy. While most babies born to mothers who had COVID-19 develop typically, researchers are studying whether the inflammatory response to SARS-CoV-2 might affect some pregnancies. A review in Frontiers in Neuroscience notes that timing, severity, and individual differences all shape outcomes.
Practical Considerations
Pregnant individuals may consider:
- Getting recommended vaccinations (like flu and COVID-19 vaccines) to prevent severe infections
- Discussing environmental concerns with healthcare providers
- Managing existing inflammatory conditions
Ongoing Research Questions
Many questions remain about how various factors interact. As noted in JAMA Network Open, disentangling specific components of environmental influences presents challenges. This research may lead to better support for neurodivergent individuals by improving our understanding of developmental pathways.
Sources
- 01Prenatal and birth factors associated with child autism diagnosis: a birth cohort perspective
- 02Prenatal maternal immune activation triggers lasting cell-specific transcriptomic dysregulation in the amygdala of primate offspring | Molecular Psychiatry
- 03Maternal immune activation as an epidemiological risk factor for neurodevelopmental disorders: Considerations of timing, severity, individual differences, and sex in human and rodent studies
- 04Characterizing the maternal immune environment during pregnancy: Implications for autism spectrum disorders
- 05Altered immune molecules during pregnancy and in the umbilical cord at birth predict later autism diagnoses
- 06Autism Spectrum Disorder and Particulate Matter Air Pollution before, during, and after Pregnancy: A Nested Case–Control Analysis within the Nurses’ Health Study II Cohort
- 07A critical prenatal risk factor for autism spectrum disorder - PubMed
- 08Prenatal Exposure to Fine Particulate Matter Components and ...
Behind the brief
Adversarial editorial review
Open thread